Abstract: The present invention relates generally to maqui berry for use in the treatment or prevention of skin diseases, wherein maqui berry may be the primary natural active ingredient. Particular embodiments as disclosed herein find application in, inter alia, the prophylaxis and the treatment of skin diseases, in particular, dermatitis, atopic dermatitis (neurodermatitis), dermatitis solaris, eczema, hand eczema, lichen planus, lupus erythematosus, psoriasis, urticaria, itching, scabies, age spot, freckles and dry/atopic skin of humans. In particular, the present invention relates to the use of maqui berry extract in the manufacture of a medicament or dietary supplement for use in treating or preventing said skin diseases or defects.

Abstract: The present invention relates generally to maqui berry for use in the treatment or prevention of bone injuries, diseases or defects, the promotion of healing of bone injuries, and the promotion of bone formation. Particular embodiments as disclosed herein find application in, inter alia, the treatment of bone fractures and in bone formation and regeneration. In particular, the present invention relates to the use of maqui berry extract in the manufacture of a medicament or dietary supplement for use in treating or preventing of bone injury or diseases or defects selected from the group of congenital bone defects, bone or spinal deformation, osteosarcoma, bone dysplasia, osteomalacia (rickets), osteogenesis imperfecta (brittle bone disorder), Paget's disease of the bone, osteoarthritis.

Abstract: The invention relates to a method for recovering monomer diisocyanates, which are solid at room temperature, from a distillation residue, said method comprising the following steps: (i) preparing at least one residue which contains diisocyanates, which are solid at room temperature, and (ii) separating the residue in at least one kneader-dryer, paddle-dryer and/or roller-dryer in the presence of less than 2 wt % bitumen, based on the mass of the residue prepared in step (i), into a gaseous portion, containing monomer diisocyanate that is solid at room temperature, and a brittle residue depleted of diisocyanate, which is solid at room temperature.